SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009447
Filing Date
2022-05-12
Accepted
2022-05-12 06:04:47
Documents
73
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dbtx-20220331.htm   iXBRL 10-Q 3095143
2 EX-31.1 dbtx-ex31_1.htm EX-31.1 18314
3 EX-31.2 dbtx-ex31_2.htm EX-31.2 19195
4 EX-32.1 dbtx-ex32_1.htm EX-32.1 10734
5 EX-32.2 dbtx-ex32_2.htm EX-32.2 10788
  Complete submission text file 0000950170-22-009447.txt   10358899

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dbtx-20220331_cal.xml EX-101.CAL 54532
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dbtx-20220331_def.xml EX-101.DEF 209251
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dbtx-20220331_lab.xml EX-101.LAB 481825
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dbtx-20220331_pre.xml EX-101.PRE 365138
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dbtx-20220331.xsd EX-101.SCH 56329
67 EXTRACTED XBRL INSTANCE DOCUMENT dbtx-20220331_htm.xml XML 1986254
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40030 | Film No.: 22915531
SIC: 2834 Pharmaceutical Preparations